Surface Oncology, Inc. Made Headway
Thu, May 21, 2020 at 05:30 PM
Surface Oncology, Inc. (SURF:NASDAQ) shot up at $5.95, representing a gain of 53.4%. On Wed 20 May 20, SURF:NASDAQ hit a New 2-Week High of $3.88. The stock appeared on our News Catalysts scanner on Wed 20 May 20 at 08:08 AM in the 'MERGER' category. From Wed 06 May 20, the stock recorded 50.00% Up Days and 54.55% Green Days
About Surface Oncology, Inc. (SURF:NASDAQ)
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.
Top 10 Gainers:
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 160.28%
- GNRS (GNRS:NASDAQ), 100%
- Surface Oncology, Inc. (SURF:NASDAQ), 53.35%
- Seneca Biopharma, Inc. (SNCA:NASDAQ), 49.69%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 46.19%
- Celsion Corporation (CLSN:NASDAQ), 36.63%
- Aurora Cannabis Inc. (ACB:NYSE), 36.47%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 35.03%
- Nabors Industries Ltd. (NBR:NYSE), 33.36%
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 31.1%